In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease

Introduction The deposition of neurofibrillary tangles in neurodegenerative disorders is associated with neuronal loss on autopsy; however, their in vivo associations with atrophy across the continuum of Alzheimer's disease (AD) remain unclear. Methods We estimated cortical thickness, tau ([18F...

Descripción completa

Detalles Bibliográficos
Autores: Mak, Elijah, Bethlehem, Richard A.I., Romero García, Rafael, Cervenka, Simon, Rittman, Timothy, Gabel, Silvy, Surendranathan, Ajenthan, O'Brien, John T.
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2018
País:España
Institución:Universidad de Sevilla (US)
Repositorio:idUS. Depósito de Investigación de la Universidad de Sevilla
OAI Identifier:oai:dnet:idus________::bf2aa73406a9863411fddb0577535066
Acceso en línea:https://hdl.handle.net/11441/185394
https://doi.org/10.1016/j.dadm.2018.08.005
Access Level:acceso abierto
Palabra clave:Alzheimer’s disease
Tau
Amyloid
Positron emission tomography
Atrophy
Cortical thickness
MRI
Descripción
Sumario:Introduction The deposition of neurofibrillary tangles in neurodegenerative disorders is associated with neuronal loss on autopsy; however, their in vivo associations with atrophy across the continuum of Alzheimer's disease (AD) remain unclear. Methods We estimated cortical thickness, tau ([18F]-AV-1451), and amyloid β (Aβ) status ([11C]-PiB) in 47 subjects who were stratified into Aβ− (14 healthy controls and six mild cognitive impairment–Aβ−) and Aβ+ (14 mild cognitive impairment–Aβ+ and 13 AD) groups. Results Compared with the Aβ− group, tau was increased in widespread regions whereas cortical thinning was restricted to the temporal cortices. Increased tau binding was associated with cortical thinning in each Aβ group. Locally, regional tau was associated with temporoparietal atrophy. Discussion These findings position tau as a promising therapeutic target. Further studies are needed to elucidate the casual relationships between tau pathology and trajectories of atrophy in AD.